Substudy - Evaluation of Patients With Iliac Vein Thrombosis

Cardioangiologisches Centrum Bethanien

Status: Completed

Conditions: Iliac Vein Thrombosis

Treatments: Genetic: thrombophilia screening

Study type: Observational

Funder types: Other

Identifiers

NCT03148548

ILIACA-PTS

Details and patient eligibility

About

Patients with previous diagnosis of iliac vein thrombosis are enrolled in this registry. Using standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded. Results of technical and laboratory investigations including screening of thrombophilic disorders were additionally entered into the database.

Enrollment: 85 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• >18 years
• subjects with iliofermoral thrombosis, which has been proven by objective measurements (Duplex sonography, phlebography, CT/MRT) later than 1996

Exclusion criteria

• <18 years
• > 80 years
• surface or deep vein thrombosis without affection of pelvis

Trial design

85 participants in 2 patient groups

Patients with iliofermoral thrombosis without rekanalisation

Description:

subjects with proven iliofemoral thrombosis (V. cava-aplasia, pelvic vein thrombosis, VTE) which was proven by objective methods such as Duplex sonography, CT/MRT, phlebography and who did not undergo recanalisation

Treatment:

Genetic: thrombophilia screening

Patients with ilifermoral thrombosis with rekanalisation

Description:

subjects with proven iliofemoral thrombosis (V. cava-aplasia, pelvic vein thrombosis, VTE) which was proven by objective methods such as Duplex sonography, CT/MRT, phlebography and who did undergo recanalisation

Treatment:

Genetic: thrombophilia screening